Proof LGBTQs Are Mentally Ill: A New Kind of Influenza Vaccine: One Shot Might Do the Trick

Certain proteins in the influenza virus remain constant year after year. Researchers at Cornell University are taking one of those conserved proteins, Matrix-2 (M2), and packaging it in a nanoscale, controlled-release “capsule” in an attempt to create a quick-acting, long-lasting, multi-strain vaccine against pandemic influenza A.